Komanduri KV - Search Results

1

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.

Wilky BA, Trucco MM, Subhawong TK, Florou V, Park W, Kwon D, Wieder ED, Kolonias D, Rosenberg AE, Kerr DA, Sfakianaki E, Foley M, Merchan JR, Komanduri KV, Trent JC. Wilky BA, et al. Among authors: komanduri kv. Lancet Oncol. 2019 Jun;20(6):837-848. doi: 10.1016/S1470-2045(19)30153-6. Epub 2019 May 8. Lancet Oncol. 2019. PMID: 31078463 Clinical Trial.

2

Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions.

Molldrem JJ, Komanduri K, Wieder E. Molldrem JJ, et al. Curr Opin Hematol. 2002 Nov;9(6):503-8. doi: 10.1097/00062752-200211000-00006. Curr Opin Hematol. 2002. PMID: 12394172 Review.

3

Vaccines in leukemia.

Lu S, Wieder E, Komanduri K, Ma Q, Molldrem JJ. Lu S, et al. Adv Pharmacol. 2004;51:255-70. doi: 10.1016/S1054-3589(04)51011-6. Adv Pharmacol. 2004. PMID: 15464913 Review. No abstract available.

4

Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells.

Kim TK, Billard MJ, Wieder ED, McIntyre BW, Komanduri KV. Kim TK, et al. Among authors: komanduri kv. Hum Immunol. 2010 Jan;71(1):23-8. doi: 10.1016/j.humimm.2009.09.360. Hum Immunol. 2010. PMID: 19815047 Free PMC article.

5

Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production.

Kim TK, St John LS, Wieder ED, Khalili J, Ma Q, Komanduri KV. Kim TK, et al. Among authors: komanduri kv. J Immunol. 2009 Nov 15;183(10):6167-74. doi: 10.4049/jimmunol.0902068. Epub 2009 Oct 19. J Immunol. 2009. PMID: 19841187

6

Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry.

Bayraktar UD, Kim TK, Drews-Elger K, Benjamin C, El-Ashry D, Wieder E, Komanduri KV. Bayraktar UD, et al. Among authors: komanduri kv. Breast Cancer Res Treat. 2011 Sep;129(2):623-8. doi: 10.1007/s10549-011-1586-z. Epub 2011 May 24. Breast Cancer Res Treat. 2011. PMID: 21607585

7

Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory.

Díaz-Montero CM, Naga O, Zidan AA, Salem ML, Pallin M, Parmigiani A, Walker G, Wieder E, Komanduri K, Cole DJ, Montero AJ, Lichtenheld MG. Díaz-Montero CM, et al. Am J Cancer Res. 2011 Aug 30;1(7):882-96. Am J Cancer Res. 2011. PMID: 21915391 Free PMC article.

8

Vitamin D receptor upregulation in alloreactive human T cells.

Joseph RW, Bayraktar UD, Kim TK, St John LS, Popat U, Khalili J, Molldrem JJ, Wieder ED, Komanduri KV. Joseph RW, et al. Among authors: komanduri kv. Hum Immunol. 2012 Jul;73(7):693-8. doi: 10.1016/j.humimm.2012.04.019. Epub 2012 Apr 28. Hum Immunol. 2012. PMID: 22548720

9

MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner.

Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV. Shindo T, et al. Among authors: komanduri kv. Blood. 2013 Jun 6;121(23):4617-26. doi: 10.1182/blood-2012-12-476218. Epub 2013 Apr 10. Blood. 2013. PMID: 23575444 Free PMC article.

10

The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression.

Komanduri KV, Wieder ED, Benjamin CL, Levy RB. Komanduri KV, et al. Immunol Res. 2013 Dec;57(1-3):140-50. doi: 10.1007/s12026-013-8461-4. Immunol Res. 2013. PMID: 24242818 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page